Search

everythinglearnresearchcommunity

for

Search:↓

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Lower SMAD2/3 activation predicts more severe skin cancer.

Including androgens in hormone therapy may lower breast cancer risk.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Targeting the Smoothened receptor shows promise for treating certain cancers.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Counterfeit drugs for bodybuilders often contain incorrect or contaminated ingredients and look like real products.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

S-Methylmethionine sulfonium can protect skin from UVB damage.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Selenium shows promise in preventing and controlling prostate cancer.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Resveratrol activates the Nrf2 pathway in human skin, significantly increasing the production and distribution of the antioxidant glutathione.

Procyanidin B2 and leucopelargonidin from Saraca asoca may help treat PCOS by balancing hormones.